title: Use of chemotherapy for ovarian cancer during human pregnancy: case report and literature review.
authors.forename: Giovanni
authors.initials: G
authors.lastname: Mantovani
authors.forename: Giulia
authors.initials: G
authors.lastname: Gramignano
authors.forename: Valerio
authors.initials: V
authors.lastname: Mais
authors.forename: Gian Benedetto
authors.initials: GB
authors.lastname: Melis
authors.forename: Giuseppina
authors.initials: G
authors.lastname: Parodo
authors.forename: Giuseppe Mario
authors.initials: GM
authors.lastname: Carrucciu
mesh_terms: D000328:Adult; D000972:Antineoplastic Agents, Phytogenic / Q000009:adverse effects / Q000627:therapeutic use*; D018283:Cystadenocarcinoma, Papillary / Q000188:drug therapy*; D005260:Female; D006801:Humans; D009367:Neoplasm Staging; D010051:Ovarian Neoplasms / Q000188:drug therapy*; D017239:Paclitaxel / Q000009:adverse effects / Q000627:therapeutic use*; D011247:Pregnancy; D011252:Pregnancy Complications, Neoplastic / Q000188:drug therapy*; D011261:Pregnancy Trimester, First
chemical_list: D000972:Antineoplastic Agents, Phytogenic; D017239:Paclitaxel